In partnership with

Greetings! Your latest quick tech update is here:

☀️ On this day: On November 16, 1974, scientists led by Frank Drake transmitted the Arecibo Message from Puerto Rico, sending 1,679 bits of binary data toward the star cluster M13. The three-minute broadcast encoded human DNA, a human figure, and Earth's position in the solar system, targeting stars roughly 25,000 light-years away. The telescope collapsed in 2020, but the message is still on its way and has covered only 52 light-years.

What’s happening:

  • 🗺️ Google Maps adds AI trip itineraries and bookings

  • 🩺 Apple launches a health AI study app

  • 📉 Intel shareholders sue after 29% stock crash

  • 🚀 Amazon’s Starlink rival just lost 40 satellites

  • 💊 FDA rejects a lung cancer drug invented in China

  • + 📊 Daily poll and results

  • + 📈 Trending tools and resources

AI Guide

200+ Proven Ways to Make Money With AI in 2026

The next wave of millionaires will be people who figured out how to make AI work for them.

The window to get ahead is still open. But not for long.

Here are 200+ proven ways to make money with AI in 2026.

Sign up for Superhuman AI, the free daily newsletter read by 1M+ professionals, and get instant access to all 200+ ways to profit from AI this year.

Hand-picked news:

🗺️ Google Maps adds AI trip itineraries ↗️LINK

  • Google Maps’ Ask Maps can now build day-by-day trip itineraries with numbered pins for every stop. Once you hit the road, it adds live traffic, business hours, and a read on each stop’s vibe.

  • Google is pushing Maps from answering questions to doing tasks. Ask Maps now finds beauty, pet care, auto, and home repair appointments and can call local businesses for you.

  • Ask Maps also expands to 30 more countries, including Spain, Germany, and the U.K. Appointment finding stays U.S.-only for now, so Europeans still have to call the salon themselves.

🩺 Apple launches a health AI study app ↗️LINK

  • Apple launched a study app with OpenEvidence that answers everyday health questions using cited medical research, and it’s recruiting up to 200,000 U.S. users 21 and older with an iPhone 15 Pro or later.

  • Apple says it wants to measure how people trust and understand health AI. Participants rate answers, fill out surveys, and can share HealthKit data like sleep, heart rate, and lab results.

  • While OpenAI says over 300 million people already ask ChatGPT health questions weekly, Apple is still running a study. It hasn’t said whether any of this will reach Siri or the Health app.

📉 Intel shareholders sue after 29% stock crash ↗️LINK

  • Intel shareholders filed a proposed class action accusing the chipmaker of hiding a prolonged PC sales slump and inventory glut before its stock plunged 28.6% on October 30.

  • The lawsuit alleges Intel withheld revenue risks while raising $23 billion through an August stock sale. Intel later forecast weaker quarterly results as memory shortages and rising prices pressured PC demand.

  • Intel's AI ambitions couldn't shield it from a struggling PC market. The October plunge erased roughly $140 billion in value, even as its shares remained up 62% for the year.

🚀 Amazon’s Starlink rival just lost 40 satellites ↗️LINK

  • United Launch Alliance’s Vulcan rocket failed about 10 minutes after liftoff on November 15, losing 40 Amazon Leo satellites in what reports describe as ULA’s first total mission failure.

  • The cause remains unknown as ULA investigates. The launch marked the first of 38 flights Amazon booked with ULA to build its Leo satellite network and compete with Starlink.

  • Amazon says it still trusts ULA, but the timing hurts: Leo already trails Starlink in deployed satellites, and its 38-flight launch plan has started with a costly setback.

💊 FDA rejects a lung cancer drug invented in China ↗️LINK

  • The FDA rejected ivonescimab, a lung cancer drug that China’s Akeso invented, Summit Therapeutics said Sunday. Summit, which holds U.S. and European rights, sought approval for advanced cases after targeted treatment.

  • The FDA said delaying cancer progression wasn’t enough without a statistically significant survival benefit. Summit’s global trial slowed the disease, but its survival gain fell short, and later unplanned analyses didn’t change regulators’ minds.

  • China approved ivonescimab back in May 2024, and Akeso already sells it there. Summit still has late-stage trials running in colorectal and other lung cancers, so this fight isn’t over.

Today’s Poll:

Do you think AI can plan a better trip than you?

Login or Subscribe to participate

Vote and find out about the result tomorrow.

Yesterday’s Poll Result:

Do you think AI stocks are overvalued right now?

  • A) Yes - 81% 🏆

  • B) No - 19%

From our partner

Your Next Revenue Stream is Hiding In Plain Sight

Your business has years of emails, documents, CRM records and call logs. AI researchers need exactly that kind of real-world data, and Mode will pay for it.

You sell a de-identified copy. Your original records and systems remain yours.

  • No broker fees. Mode buys directly.

  • You approve what data gets shared.

  • You never share your passwords.

  • Sensitive information is removed before delivery.

  •  It takes just a few hours of your team’s time.

Depending on data volume and a full review, companies with several years of records could see 100K–5M.

See if your company qualifies and get a quote.

AI for Managers by Microsoft (free course): In this learning path, managers at all levels of the organization will learn practical ways to enhance their effectiveness with generative AI.

Meco (free app): Meco is a distraction-free space for reading and discovering newsletters, separate from the inbox. Add your newsletters in seconds and liberate your inbox today!

Gamma: Create unlimited presentations, websites, and more in seconds. Everything you need to quickly create and refine content with AI.

Granola: AI notepad that turns your messy meeting notes into clean, structured summaries.

Better Pic: Get Studio Quality AI professional headshots, without a photographer or a photoshoot.